Analysts Set HCP Inc. (NYSE:HCP) PT at $34.10
HCP Inc. (NYSE:HCP) has been given a consensus recommendation of “Hold” by the nineteen analysts that are currently covering the stock. Seven analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $34.10.
Several equities analysts have recently weighed in on HCP shares. BTIG Research started coverage on shares of HCP in a research note on Thursday, August 25th. They issued a “neutral” rating on the stock. Wells Fargo & Co. reissued a “hold” rating on shares of HCP in a research note on Sunday, September 4th. Zacks Investment Research downgraded shares of HCP from a “buy” rating to a “hold” rating in a research note on Monday. Mizuho reaffirmed a “hold” rating and set a $32.00 target price on shares of HCP in a research note on Tuesday, July 12th. Finally, Goldman Sachs Group Inc. raised shares of HCP from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $26.00 to $36.00 in a research note on Friday, July 8th.
In other HCP news, EVP Jonathan M. Bergschneider sold 7,651 shares of the business’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $39.78, for a total transaction of $304,356.78. Following the completion of the transaction, the executive vice president now owns 54,095 shares in the company, valued at approximately $2,151,899.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Kendall K. Young sold 9,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 24th. The stock was sold at an average price of $39.46, for a total transaction of $355,140.00. Following the transaction, the insider now owns 36,183 shares of the company’s stock, valued at approximately $1,427,781.18. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Acadian Asset Management LLC purchased a new position in HCP during the first quarter valued at approximately $701,000. Glenmede Trust Co. NA boosted its position in shares of HCP by 1.0% in the first quarter. Glenmede Trust Co. NA now owns 43,235 shares of the real estate investment trust’s stock valued at $1,407,000 after buying an additional 428 shares during the last quarter. Mn Services Vermogensbeheer B.V. bought a new position in shares of HCP during the first quarter valued at about $332,000. Virginia Retirement System bought a new position in shares of HCP during the first quarter valued at about $6,458,000. Finally, IFP Advisors Inc boosted its position in shares of HCP by 171.7% in the first quarter. IFP Advisors Inc now owns 53,993 shares of the real estate investment trust’s stock valued at $1,759,000 after buying an additional 34,118 shares during the last quarter. Institutional investors own 90.96% of the company’s stock.
HCP (NYSE:HCP) opened at 38.54 on Tuesday. HCP has a 1-year low of $25.11 and a 1-year high of $40.43. The stock’s 50 day moving average is $38.86 and its 200-day moving average is $35.89. The company’s market capitalization is $18.02 billion.
HCP (NYSE:HCP) last posted its quarterly earnings results on Tuesday, August 9th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.04. The firm had revenue of $662.20 million for the quarter, compared to the consensus estimate of $631.25 million. HCP had a negative net margin of 2.52% and a negative return on equity of 0.67%. The company’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period last year, the firm posted $0.79 earnings per share. On average, analysts expect that HCP will post $2.83 earnings per share for the current fiscal year.
HCP Company Profile
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
Receive News & Stock Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related stocks with our FREE daily email newsletter.